跳至主要内容
临床试验/ITMCTR2100004859
ITMCTR2100004859尚未招募1 期

Pediatric Tuina for functional constipation in children: a randomized controlled clinical trail

School of Second Clinical Medicine, Yunnan University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
1 至 7(—)
性别
All

入选标准

  • 1. Children aged 1-7 years;
  • 2. Children who meet the diagnostic criteria for functional constipation (Rome IV);
  • (1) Must include 1 month of at least 2 of the following in infants up to 4 years of age:
  • 1) 2 or fewer defecations per week;
  • 2) History of excessive stool retention;
  • 3) History of painful or hard bowel movements;
  • 4) History of large-diameter stools;
  • 5) Presence of a large fecal mass in the rectum. In toilet-trained children, the following additional criteria may be used:
  • 6) At least 1 episode/week of incontinence after the acquisition of toileting skills;
  • 7) History of large-diameter stools that may obstruct the toilet.
  • (2) For children over 4 years of age, there must include 2 or more of the following occurring at least once per week for a minimum of 1 month with insufficient criteria for a diagnosis of irritable bowel syndrome:
  • 1) 2 or fewer defecations in the toilet per week in a child of a developmental age of at least 4 years;
  • 2) At least 1 episode of fecal incontinence per week;
  • 3) History of retentive posturing or excessive volitional stool retention;
  • 4) History of painful or hard bowel movements;
  • 5) Presence of a large fecal mass in the rectum;
  • 6) History of large diameter stools that can obstruct the toilet;
  • 3. Parents or legal guardians are motivated to participate in the trial;
  • 4. Parents or legal guardians' sign was written informed consent.

排除标准

  • 1. A history of intestinal surgery;
  • 2. Receiving gastrointestinal prokinetic agent or laxative treatments 14 days before enrollment;
  • 3. Receiving pediatric Tuina or probiotics 14 days before enrollment;
  • 4. Children with Hirschsprung's disease;
  • 5. Children with neurological and psychiatric disorders (e.g., cerebral palsy, autism, spina bifida, anorexia nervosa);
  • 6. Children with any organic or metabolic diseases of hematopoietic, endocrine, immune systems.

研究者

发起方
School of Second Clinical Medicine, Yunnan University of Chinese Medicine

相似试验